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Regulation of retinal pigment 
epithelial cell phenotype by 
Annexin A8
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Ursula Rescher3, John Greenwood1 & Stephen E. Moss1
The retinoic acid derivative fenretinide (FR) is capable of transdifferentiating cultured retinal pigment 
epithelial (RPE) cells towards a neuronal-like phenotype, but the underlying mechanisms are not 
understood. To identify genes involved in this process we performed a microarray analysis of RPE 
cells pre- and post-FR treatment, and observed a marked down-regulation of AnnexinA8 (AnxA8) in 
transdifferentiated cells. To determine whether AnxA8 plays a role in maintaining RPE cell phenotype 
we directly manipulated AnxA8 expression in cultured and primary RPE cells using siRNA-mediated 
gene suppression, and over-expression of AnxA8-GFP in conjunction with exposure to FR. Treatment 
of RPE cells with AnxA8 siRNA recapitulated exposure to FR, with cell cycle arrest, neuronal 
transdifferentiation, and concomitant up-regulation of the neuronal markers calretinin and calbindin, 
as assessed by real-time PCR and immunofluorescence. In contrast, AnxA8 transient over-expression 
in ARPE-19 cells prevented FR-induced differentiation. Ectopic expression of AnxA8 in AnxA8-depleted 
cells led to decreased neuronal marker staining, and normal cell growth as judged by phosphohistone 
H3 staining, cell counting and cleaved caspase-3 levels. These data show that down-regulation of AnxA8 
is both necessary and sufficient for neuronal transdifferentiation of RPE cells and reveal an essential role 
for AnxA8 as a key regulator of RPE phenotype.
Retinal pigment epithelial (RPE) cells and the retina are developmentally derived from the same tissue; the optic 
vesicle neuroectoderm, and throughout life RPE cells perform a variety of functions to support and protect the 
retina. These include phagocytosis of photoreceptor outer segments1, adsorption of free radicals by pigment gran-
ules2 and maintenance of ocular immune privilege by forming the outer blood-retina barrier3.
Another striking feature of RPE cells, in some species, is their capacity to transdifferentiate into precursor 
cells and regenerate neuronal tissue. Accordingly, in urodele amphibians such as newts, complete retinal regen-
eration occurs via RPE transdifferentiation following ocular neuronal injury regardless of life stage4, 5. In mam-
mals, however, the ability of RPE cells to transdifferentiate in vivo is lost during early embryonic development. 
Therefore, neuronal cell injury, of the type that occurs in neurodegenerative diseases such as retinitis pigmentosa 
or age-related macular degeneration, usually results in irreversible vision loss6, 7. However, there is evidence that 
despite being largely post-mitotic, some mature RPE cells continue to divide8, 9 mostly in the peripheral retina10, 
as well as during pathological complications following retinal detachment that lead to proliferative vitreoretin-
opathy11. In contrast, when cultured ex vivo, RPE cells can be highly proliferative, though this is usually accom-
panied by substantial de-differentiation manifested as loss of pigment granules, cell polarity and expression of 
key RPE cell genes such as RPE65 and the Mer tyrosine kinase. Various studies have shown that under suitable 
conditions, a more authentic RPE cell phenotype can be restored, demonstrating the phenotypic plasticity of these 
cells in culture12. Conversely, RPE transdifferentiation can be induced in vitro by basic fibroblast growth factor 
(bFGF) or retinoic acid (RA)13–15, factors known to play a key role in RPE reprogramming during development 
and retinal regeneration in urodeles16.
In this study, the RA derivative Fenretinide (FR) was used to induce transdifferentiation of RPE cells towards 
a neuronal-like phenotype as described previously15, 17. FR exerts its properties in a similar manner to RA; upon 
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binding to nuclear RA receptors (RARs), RARs dimerise with retinoid-X-receptors and activate the RA response 
element (RARE), leading to transcription of target genes18–20. Here we performed a microarray analysis to iden-
tify genes involved in the FR-induced transdifferentiation of RPE cells, and observed that AnxA8 was strongly 
down-regulated upon 7 days exposure to FR. We had a particular interest in AnxA8 and its role in FR-mediated 
changes, since it was previously associated with osteoclast differentiation21. AnxA8 is one of 12 human annexins, 
most of which share the ability to bind calcium-dependently to negatively-charged phospholipid membranes. 
Annexins are implicated in cell growth and proliferation22, 23, vesicle trafficking24, and membrane and cytoskel-
etal organization25. AnxA8 was first identified as vascular anticoagulant-β in the human placenta, where it was 
described to inhibit blood coagulation and phospholipase A226. AnxA8 has been linked with endosome formation 
in Hela cells27, and it plays a role in leukocyte recruitment through exposing cell surface markers on endothelial 
cells such as CD63 and P-selectin28. We show here that suppression of AnxA8 phenocopies the effects of FR, and 
is both necessary and sufficient to induce neuronal transdifferentiation of RPE cells. These observations identify 
a novel role for AnxA8 as a key regulator of RPE phenotype.
Results
FR and AnxA8 siRNA suppress AnxA8. We undertook a microarray analysis of FR-treated ARPE-19 
cells in order to identify genes that might mediate the effects of FR. As expected, and consistent with published 
observations15, 17, we observed an increase in the expression of the neuronal marker calretinin in response to 
FR, and strong down-regulation of AnxA8, a gene which has been linked with cell differentiation processes21 
(Table 1). To validate the microarray data, we performed immunofluorescence analysis of AnxA8 in FR- and 
dimethyl sulfoxide (DMSO) control-treated cells, which showed that FR treatment led to almost complete dis-
appearance of AnxA8 staining in both ARPE-19 cells (Fig. 1A) and primary porcine RPE (pRPE) cells (Fig. 2A). 
Real-time polymerase chain reaction (PCR) analysis revealed a ~70% down-regulation of AnxA8 expression in 
both FR-treated ARPE-19 (Fig. 1B) and pRPE cells (Fig. 2B). To elucidate whether AnxA8 has a causative role 
in transdifferentiation or is suppressed as a consequence, short interfering ribonucleic acid (siRNA) was used to 
suppress AnxA8 gene expression in RPE cells. Immunostaining revealed that following siRNA treatment, AnxA8 
was barely detectable in both ARPE-19 (Fig. 1A) and pRPE cells (Fig. 2A). Furthermore, DAPI and phalloidin 
staining showed a marked reduction in cell number and the formation of extensions in the absence of AnxA8 that 
resembled those observed with FR.
FR and AnxA8 siRNA induce a neuronal-like phenotype. To further examine the role of AnxA8 in 
determining RPE phenotype, we used phase images of FR- or AnxA8 siRNA-treated RPE cells to visualise cellular 
morphology. As reported previously15, 17, FR induced an arrest in cell growth and formation of neuron-shaped 
extensions in ARPE-19 cells, whereas DMSO control-treated cells showed a more normal epithelial phenotype 
and higher cell density. Similar morphological changes were observed after siRNA-mediated AnxA8 depletion 
(Fig. 3A), and pRPE cells displayed comparable features in response to FR and AnxA8 siRNA treatment regarding 
cell morphology changes (Fig. 2C). Furthermore, the neuronal markers calretinin and calbindin were signifi-
cantly upregulated to a similar extent in both FR- and AnxA8 siRNA-treated ARPE-19 cells as demonstrated 
by real-time PCR (Fig. 3B). Immunofluorescence imaging revealed a marked increase in staining intensity for 
calretinin and calbindin upon exposure to FR and AnxA8 siRNA, as well as a change in subcellular localisation 
from exclusively nuclear to both nuclear and cytosolic. The staining also emphasises the formation of the char-
acteristic neuronal-like extensions between the cells, and changes to the F-actin cytoskeleton (Fig. 3C). To deter-
mine whether the acquisition of neuronal characteristics was accompanied by loss of hallmark RPE features, we 
examined the expression of a number of RPE cell markers (retinaldehyde binding protein 1, keratin 8, bestrophin 
1, tyrosinase, tyrosinase related protein 1, premelanosome protein, monocarboxylate transporter 3, mer tyrosine 
kinase, paired box 6, orthodenticle homeobox 2, growth arrest specific 1, melanogenesis associated transcription 
factor) in FR- or AnxA8 siRNA treated ARPE-19 cells. However, without exception these were either expressed 
at very low levels or undetectable (results not shown), consistent with our previous study15. Taken together with 
the data in Fig. 1, these observations show that down-regulation of AnxA8 is sufficient to induce neuronal char-
acteristics in RPE cells.
AnxA8 over-expression inhibits FR-induced changes in morphology. We next wanted to find out 
whether suppression of AnxA8 was necessary for the FR-induced transdifferentiation of RPE cells. For these 
experiments we performed transient ectopic expression of AnxA8-GFP or GFP (as control) in RPE cells imme-
diately prior to treatment with either FR or DMSO (Fig. 4A). By day 3 of FR or DMSO treatment, FR induced 
neuronal-like transdifferentiation of control GFP-transfected cells as was seen in neighbouring non-transfected 
cells (yellow arrow). The respective DMSO control had no effect on the cell morphology of either AnxA8-GFP- or 
GFP-transfected cells. However, when exposed to FR for 3 days, cells transfected with AnxA8-GFP remained in 
an undifferentiated state with no extension formation, while adjacent, non-transfected cells exhibited the char-
acteristic neuronal-like morphological changes (red arrows). The percentage of GFP-expressing extensions was 
25% on day 3 of FR treatment, and 43% on day 6, consistent with the on-going acquisition of neuronal charac-
teristics in the growth-arrested cells. In contrast, AnxA8-GFP-transfected cells never formed extensions when 
treated with FR (Fig. 4B). By day 6, the relative number of cells expressing control GFP was unchanged from 
day 0 whether cells were treated with DMSO or FR (Fig. 4C). However, by day 6 the percentage of AnxA8-GFP 
positive cells diminished in control and FR-treated cells to 34% and 22% respectively, suggesting that together 
with the loss of expression one would anticipate in a transient transfection study, sustained over-expression of 
AnxA8-GFP may not be well tolerated by RPE cells, particularly in the presence of FR.
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AnxA8 over-expression inhibits FR-induced changes in gene expression. We also wanted to deter-
mine whether forced expression of AnxA8-GFP would prevent the increase in expression of calbindin and cal-
retinin observed upon treatment of ARPE-19 cells with FR or AnxA8 siRNA. Cells were transfected with GFP 
or AnxA8-GFP, and then cultured in FR or treated with AnxA8 siRNA for 3 days (with appropriate controls) 
prior to analysis by confocal microscopy. Treatment with both FR and AnxA8 siRNA led to a reduction in cell 
proliferation in GFP-transfected cells, with concomitant formation of neuronal extensions and increased staining 
intensity for calbindin and calretinin (Fig. 5A,B). In contrast, in cultures transfected with AnxA8-GFP and then 
treated with FR or AnxA8 siRNA, most of the transfected cells exhibited markedly reduced staining intensity for 
Probe ID Gene symbol Gene name Fold change P value
206658_at UPK3B uroplakin 3B −6.94642 1.38E-07
206758_at EDN2 endothelin 2 −5.78156 2.48E-08
211029_x_at FGF18 fibroblast growth factor 18 −5.67398 7.78E-10
219054_at C5orf23 chromosome 5 open reading frame 23 −5.44576 5.92E-08
211959_at IGFBP5 Insulin-like growth factor binding protein 5 −5.27773 4.60E-06
203074_at ANXA8 annexin A8 −4.63574 5.14E-10
219790_s_at NPR3 natriuretic peptide receptor −4.3291 1.96E-07
219937_at TRHDE thyrotropin-releasing hormone degrading enzyme −3.9654 1.49E-07
223063_at C1orf198 chromosome 1 open reading frame 198 −3.75853 2.50E-08
201564_s_at FSCN1 fascin homolog 1 −3.67614 2.37E-07
209292_at ID4 Inhibitor of DNA binding 4 −3.6008 2.31E-09
204451_at FZD1 frizzled homolog 1 (Drosophila) −3.28944 4.37E-08
228885_at RPL24 ribosomal protein L24 −3.24399 1.39E-07
218931_at RAB17 RAB17, member RAS oncogene family −3.20924 2.18E-09
20364_s_at COBLL1 COBL-like 1 −3.18439 1.64E-07
207787_at KRT keratin 33B −3.14621 2.54E-07
217841_s_at PPME1 protein phosphatase ethyl esterase 1 −2.7241 1.16E-07
240890_at CASP4 caspase 4 −2.63728 3.68E-09
212158_at SDC2 syndecan 2 −2.55582 9.17E-08
209082_s_at Col18A1 collagen type XVII −2.01389 1.19E-07
201366_at ANXA7 annexin A7 1.38439 5.73E-06
205428_s_at CALB2 calbindin 2 (calretinin) 2.87484 1.24E-05
209278_s_at TFPI2 tissue factor pathway inhibitor 2 2.93228 5.23E-08
201425_at ALDH2 aldehyde dehydrogenase 2 family 2.94253 1.27E-07
214453_s_at IFI44 interferon-induced protein 44 3.172 7.16E-07
205110_at FGF13 fibroblast growth factor 13 3.25386 1.78E-08
205047_at ASNS asparagine synthetase 3.30353 4.79E-08
223062_s_at PSAT1 phosphoserine aminotransferase 1 3.31132 7.38E-07
214430_at GLA galactosidase, alpha 3.39277 2.68E-06
205730_s_at ABLIM3 actin binding LIM protein family, member 3 3.45524 6.46E-07
205479_s_at PLAU plasminogen activator, urokinase 3.51411 1.38E-06
238133_at NTNG1 netrin G1 3.52826 1.64E-06
213112_s_at SQSTM1 sequestosome 1 3.87001 1.03E-06
208025_s_at HMGA2 high mobility group AT-hook 2 4.14352 5.32E-07
212298_at NRP1 neuropilin 1 4.62486 4.84E-06
203505_at ABCA1 ATP-binding cassette 5.71048 7.09E-08
202859_x_at IL8 interleukin 8 6.38496 1.64E-07
211506_s_at IL18 interleukin 18 6.42257 1.07E-08
206172_at IL13RA2 interleukin 13 receptor, alpha 2 6.44241 2.16E-07
219926_at POPCD3 Popeye domain containing 3 6.82434 8.44E-08
Table 1. Microarray data pre- and post-FR treatment showing 40 of the most up- and down-regulated genes 
and their fold change in response to FR versus control treatment. AnxA8 was one of the most down-regulated 
genes, while AnxA7 was almost unchanged. The neuronal marker calretinin was up-regulated in FR-treated 
ARPE-19 cells.
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calretinin (yellow arrows in Fig. 5A) and calbindin (yellow arrows in Fig. 5B) than their non-transfected neigh-
bours. In these experiments the ectopic expression of AnxA8-GFP was sufficiently high as to be unaffected by 
the siRNA.
AnxA8 siRNA and FR induce cell cycle arrest and apoptosis. Finally, we performed experiments to 
quantify the effects of neuronal transdifferentiation on cell proliferation, since the results of the earlier studies 
suggested that FR and AnxA8 siRNA both induced cell growth arrest in ARPE-19 and pRPE cells. ARPE-19 cells 
were transfected with GFP or AnxA8-GFP and then cultured in FR or treated with AnxA8 siRNA for 6 days 
Figure 1. Suppression of AnxA8 phenocopies FR in RPE cells. (A) Immunofluorescence staining for AnxA8 
(green) is decreased in response to both FR (7 days) and AnxA8 siRNA in ARPE-19 cells whereas vehicle 
(DMSO) and control siRNA had no effect. Nuclei were stained with DAPI (blue), and rhodamine phalloidin 
(red) revealed cell extensions in FR- or AnxA8 siRNA-treated cells (yellow arrows in insets). Experiments were 
performed three times and representative images are shown, scale bar = 50 µm. (B) Expression levels of AnxA8 
were analysed with real-time PCR. Both FR and AnxA8 siRNA elicited significant reductions in the level of 
AnxA8 mRNA. Shown are mean and standard error of five independent experiments. Student’s t-test was used 
to calculate statistical significance (***=P < 0.001).
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Figure 2. Primary porcine RPE respond to FR and AnxA8 siRNA in the same way as ARPE-19 cells. (A) FR 
and AnxA8 siRNA treatment for 7 days results in fewer cells (DAPI, blue), formation of cytoplasmic extensions 
and F-actin rich domains at the cell borders (rhodamine phalloidin, red) with concomitant down-regulation of 
AnxA8 (green). Scale bar = 50 μm. Shown are representative immunofluorescence images from 3 independent 
experiments. (B) Cell lysates were prepared under each of the conditions shown in (A) and AnxA8 siRNA levels 
were quantified by real-time PCR. Similar to ARPE-19 cells, porcine AnxA8 mRNA transcripts were down-
regulated in the presence of FR and AnxA8 siRNA. Data show mean and standard error from 5 independent 
experiments. Student’s t-test was used to calculate statistical significance (***=P < 0.001). (C) Representative 
phase images show that FR and AnxA8 siRNA treatment both lead to extension formation and suppression of 
cell growth as observed in ARPE-19 cells. Scale bar = 100 μm.
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before being fixed and immunostained for the mitotic marker pHH3 (Fig. 6A). Quantification of the number of 
pHH3+ cells in the GFP-transfected cultures confirmed the near complete absence of mitotic cells in the presence 
of FR or following AnxA8 siRNA treatment, whereas ectopic expression of AnxA8-GFP restored the number 
Figure 3. Loss of AnxA8 leads to up-regulation of neuronal markers in RPE cells. (A) Phase images of FR- or 
AnxA8 siRNA-treated ARPE-19 cells show reduced cell growth and formation of neuronal-like extensions 
compared to respective controls. Experiments were performed three times and representative images are shown, 
scale bar = 100 μm. (B) mRNA was extracted from ARPE-19 cells following treatment with FR or AnxA8 siRNA 
and subjected to real-time PCR analysis for calretinin and calbindin. The results show that both genes were 
significantly up-regulated by FR and AnxA8 siRNA (** = P < 0.01, *** = P < 0.001, n = 4). (C) ARPE-19 cells 
were treated with FR and AnxA8 siRNA, then fixed, immunostained and visualized by confocal microscopy. 
Calretinin and calbindin (both green) were stained along with nuclei (DAPI, blue) and F-actin (rhodamine 
phalloidin, red). Calretinin and calbindin staining in cells treated with FR and AnxA8 siRNA was markedly 
enhanced and more evident in the cytosol, scale bar = 50 μm.
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of pHH3+ cells to control levels (Fig. 6B). We also counted total cell numbers under each of these experimental 
conditions to demonstrate that the absence of mitotic cells in the FR- and AnxA8 siRNA-treated cultures was 
not due to a lack of cells. This analysis revealed that in GFP control transfected cultures the total cell number 
after FR and AnxA8 siRNA treatment was around one third of that in cultures transfected with AnxA8-GFP 
(Fig. 6C). We also performed western blotting analysis to determine whether AnxA8-loss induced apoptosis. 
Control GFP-transfected ARPE-19 cells treated with FR and AnxA8 siRNA showed a significant increase in 
cleaved caspase-3 (Figs 6D and S1). AnxA8-GFP transfected cells, however, exhibited lower levels of cleaved 
caspase-3 and rescued caspase-3 levels in FR- or AnxA8 siRNA-treated cells.
Figure 4. Ectopic expression of AnxA8 prevents FR-induced neuronal transdifferentiation. (A) Merged phase 
and fluorescence images of AnxA8-GFP- and GFP-transfected ARPE-19 cells, treated with either FR or the 
DMSO control for 0, 3 and 6 days. FR-induced transdifferentiation was observed in GFP-transfected (yellow 
arrow in inset) or non-transfected cells only (red arrows in inset). (B) Quantification of ARPE-19 cell extensions 
revealed 25% and 43% of GFP transfected extensions on day 3 and day 6 respectively of FR treatment, while 
AnxA8-GFP was never found in FR-induced cell extensions. Six representative images from four independent 
experiments were counted. (C) Quantification of the number of transfected cells at different stages of the 
experiment revealed that the initial transfection rate of the starting transfection rate of ~50% was maintained 
in GFP transfected cells after 6 days, whereas the proportion of AnxA8-GFP-transfected cells diminished to 
~32% in DMSO and ~20% in FR. Data are mean and standard error of four independent experiments. For each 
experiment cells from 6 representative images were counted. Student’s t-test was used to calculate statistical 
significance (* = P < 0.05).
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Discussion
RPE cells perform a range of unique functions to support and protect photoreceptor cells and maintain the 
visual cycle29. These highly specialised properties require RPE cells to be terminally differentiated in vivo. In 
most mammalian species it is generally considered that mature RPE cells are post-mitotic, with little evidence 
for self-renewal or regression to a precursor cell stage11. In contrast, RPE cells in vitro tend to spontaneously 
de-differentiate and have been shown to acquire some of the characteristics of other retinal cell types, including 
ganglion, amacrine, photoreceptor, and glial cells30, 31. This apparent plasticity of RPE cells is also supported by 
evidence that they can be induced to transdifferentiate towards a neuronal-like phenotype15, 17. These observa-
tions reveal an inherent stemness in RPE cells more commonly seen in newts and other urodeles that have the 
capacity for retinal regeneration in vivo. Interestingly, the constraints on RPE cell division in mammals appear to 
be lifted under certain pathological conditions such as retinal detachment32 or tumour growth33.
To gain insight into the molecular mechanisms that regulate RPE phenotype we exploited the established 
model of FR-induced neuronal transdifferentiation15, 17. Microarray analysis of gene expression pre- and post-FR 
revealed AnxA8 to be among the most strongly down-regulated genes in transdifferentiated RPE cells. AnxA8 
is specifically expressed in cells of patients with acute promyelocytic leukaemia (APL)34–36, indicating a role in 
differentiation of haematopoietic cells. Elevated AnxA8 expression levels are associated with terminal osteoclast 
differentiation21, and AnxA8 was recently documented to be present in mouse mammary ductal epithelium37. 
Transcriptomic analysis of human primary RPE also revealed the presence of AnxA838, consistent with its expres-
sion in ARPE19 cells observed here.
To address this question, AnxA8 was targeted in RPE cells using siRNA. Interestingly, loss of AnxA8 revealed 
almost identical phenotypic changes to those induced by FR, including reduced cell proliferation, formation 
of neuronal-like extensions and concomitant upregulation of neuronal markers. FR has been shown before to 
increase the expression of neurofilament proteins NF160 and NF200, and induce strong immunostaining of cal-
retinin15, 17. A reduction in cell number and formation of extensions have also been reported in endothelial and 
tumour cells after exposure to FR39, 40.
These experiments showed that suppression of AnxA8 is sufficient to cause acquisition of a neuronal pheno-
type. But we also wanted to know whether suppression of AnxA8 was necessary for the FR-induced phenotypic 
switch. We therefore transiently over-expressed AnxA8-GFP while exposing the cells to FR. Within the mixed 
population of transfected and non-transfected cells, those over-expressing AnxA8 were resistant to FR-or AnxA8 
siRNA-induced changes. This shows that ectopic expression of AnxA8-GFP can substitute for endogenous AnxA8 
and preserve RPE phenotype. However, we also observed a greater time-dependent decrease in the number of 
AnxA8-GFP-transfected cells in FR-treated versus control cells, suggesting that AnxA8-GFP expression is less 
well tolerated in the presence of FR and/or the transient expression ceased.
Our findings reveal that AnxA8 is required for maintenance of a normal RPE phenotype, and that loss of 
AnxA8 may result in RPE reprogramming towards neuronal-like cells. It is interesting to note that AnxA8 has 
Figure 5. Suppression of AnxA8 is required for induction of calretinin and calbindin. (A) Cells were 
transfected with either GFP or AnxA8-GFP and then treated with FR or AnxA8 siRNA (with appropriate 
controls) for 3 days. Images show elevated staining for calretinin (red) upon exposure to FR and AnxA8 siRNA, 
with the merged images showing GFP (green) and nuclei (DAPI, blue). In cells transfected with AnxA8-GFP 
we observed many instances where there was no apparent increase in expression of calretinin (yellow arrows) 
following FR or AnxA8 siRNA when compared to DMSO control and control siRNA treatments. Presented are 
representative images from three independent experiments, scale bar = 50 μm. Similar analysis of calbindin (B) 
in the same set of experimental conditions revealed patterns of expression almost identical to those described 
above for calretinin.
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Figure 6. Cell cycle arrest and apoptosis in the presence of FR requires suppression of AnxA8. (A) ARPE-19 
cells were transfected with GFP or AnxA8-GFP, then treated with FR or AnxA8 siRNA for 3 d before being fixed 
and immunostained for phosphohistone H3 (pHH3). GFP-transfected ARPE-19 cells showed a reduction in 
the number of nuclei (DAPI, blue) and in contrast to confluent control samples, almost no cells were positive 
for pHH3 (red) when treated with FR or AnxA8 siRNA. In AnxA8-GFP-transfected cells, similar numbers of 
pHH3 positive cells were observed in all conditions. Scale bar = 50 μm. (B) Quantitation of pHH3-positive cells 
under each of the conditions shown in (A) employed data from 4 individual experiments, using 5 representative 
areas for counting. The number of pHH3 positive cells was significantly reduced in GFP-expressing cells in the 
presence of FR or AnxA8 siRNA and this was completely reversed by expression of AnxA8-GFP. (C) Total cell 
number followed a similar pattern to the proportion of dividing cells, with fewer cells per mm2 following FR or 
AnxA8 siRNA, and reversal of this effect by ectopic expression of AnxA8-GFP. (D) While caspase-3 was slightly 
diminished in control GFP-transfected ARPE-19 cells treated with either FR or AnxA8 siRNA, there was a 
significant increase in cleaved caspase-3 in these samples as judged by western blotting (cropped images). Mean 
and standard deviations were obtained from 3 independent experiments. Student’s T-test was used to calculate 
statistical significance (* = P < 0.05, ** = P < 0.01, *** = P < 0.001).
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previously been described as a marker of terminal differentiation of osteoclasts21, 41. AnxA8 was also shown to 
modulate proliferation in the mammary gland epithelial cell line Kim-2, in studies in which ectopically expressed 
AnxA8 triggered senescence-associated changes37. Our data indicate that FR regulates cell growth arrest, cell 
cycle arrest, apoptosis and trans-differentiation of RPE cells with associated up-regulation of the neuronal 
markers calretinin and calbindin, via down-regulation of AnxA8. Consistent with this assumption are data that 
showed down-regulation of AnxA8 by retinoic acid to be associated with maturation and differentiation of the 
APL-derived model cell line NB442. AnxA8 expression was completely suppressed in response to all-trans RA, with 
reduced proliferation and complete regression of APL, accompanied by an inverse correlation between RAR-α 
and AnxA8 expression34, 36. Changes in RPE phenotype associated with AnxA8 loss might therefore be mediated 
through the RA signalling pathway, and a decrease in AnxA8 might be necessary for this pathway to be activated.
Although AnxA8 seems to play a major role in maintaining RPE cell phenotype and its suppression leads to neu-
ronal trans-differentiation in culture, its role in vivo and its potential interaction with other proteins remains unre-
solved. In addition, caution is required in extrapolating findings obtained in an in vitro culture model to the complex 
environment of the living retina. In future studies it will be of interest to examine potential interactions between 
AnxA8 and other developmental factors, such as Wnt signaling genes, sonic hedgehog or the bone morphogenetic 
proteins, all of which are involved in retinal regeneration43–45. In addition to cell-intrinsic factors, choroidal tissue 
may be important for RPE cell transdifferentiation into neurons, suggesting that interactions between RPE cells and 
their environment may also stimulate transdifferentiation46. This idea is supported by work showing that laminin 
in the vascular membrane of the choroid can promote RPE transdifferentiation47. Essential factors mediating these 
choroid-RPE interactions in newts as well as chick embryos are FGF-2 and IGF-146, 48, which were detected in 
RPE cells and in macrophages migrating into the eye cavity in the early stages of retina regeneration49. Further, 
gene transcripts encoding FGF receptors were discovered in RPE cells of chick and mammalian embryos50, 51. 
In summary, we have shown that the well-documented effects of FR on RPE cell phenotype are potentially medi-
ated through down-regulation of AnxA8, and that this is both necessary and sufficient for neuronal transdifferen-
tiation. In the context of tissue regeneration in urodeles it is intriguing to note that among all vertebrates, this is the 
only order that contains orthologues of the complete mammalian annexin gene family, yet lacks AnxA8.
Methods
Isolation and cultivation of porcine RPE. Pig eyes were obtained from Link (Wolverhampton, UK) and 
kept on ice during transport and preparation. Eyes were disburdened from muscle tissue, cleaned with videne 
(Ecolab) and phosphate-buffered saline (PBS) 1:5 and incubated in 0.2 mg/ml penicillin/streptomycin for 30 min 
at 4 °C. Under sterile conditions, the eyes were circularly cut underneath the Ora serrata. The neuroretina was 
detached from the subjacent RPE cells and disconnected from the optical nerve. RPE cells were incubated with 
10× trypsin-ethylene diamine tetra acetic acid (EDTA, Gibco) for 20 min at 37 °C and detached by pipetting up 
and down. Cells were centrifuged at 400× g for 5 min and plated in DMEM and 10% FBS.
Cell culture. Human ARPE-19 cells (ATCC number CRL-2302)52 and primary RPE (pRPE) cells from pigs 
were cultured in Dulbecco’s modified Eagle’s medium and Ham’s F12 1:1 (DMEM/F12, Gibco) at 37 °C with 5% 
carbon dioxide. The media was supplemented with 100 U/ml penicillin/streptomycin (Gibco) and 10% foetal 
bovine serum (FBS, Gibco).
FR treatment. Cells were seeded into flat-bottom 6-well dishes at 2,200 cells/cm2 and allowed to attach 
overnight. DMEM and 3% charcoal dextran-treated FBS (Thermo Scientific Hyclone) were added for another 
24 h to adsorb hormones and growth factors. Cells were then treated with 1 µM FR (Tocris, Bioscience) or DMSO 
(Sigma) as control in DMEM and 1% FBS every day for 7 days. Subsequently, phase images were obtained (Leica 
DC200) and cells were processed for real-time PCR and immunofluorescence staining.
Microarray Analysis. Total RNA was extracted from cells following 7 days treatment with DMSO or 
Fenretinide, using TriZol reagent (Life Technologies) and purified (RNeasy Mini Kit, Qiagen) according to the 
manufacturers instructions. cDNA was synthesised using Superscript II and E.Coli DNA polymerase according 
to the manufacturers instructions (Life Technologies), purified (GeneChip® Sample Cleanup Module, Qiagen) 
and used as a template for the synthesis of biotin-labelled cRNA (GeneChip IVT Labeling Kit (Affymetrix). The 
biotin-labelled cRNA was purified and fragmented using the GeneChip® Sample Cleanup Module. cRNAs were 
hybridised to the Human U133A 2.0 Affymetrix Microarray. Data analysis was performed in R using packages from 
Bioconductor53. Data sets for each array were quality assessed using affyQCReport. GenChip Robust Multiarray 
averaging (GC-RMA) was used to correct background, normalise data and convert fluorescence into expression 
levels. Differentially expressed genes were identified using a two sample T-test followed by FDR analysis.
Suppression of AnxA8. RPE cells were plated in full media and allowed to attach. SiRNA transfection was 
carried out at 80% cell confluence using a pool of AnxA8 siRNA (Life Technologies) with the following sequences: 
human AnxA8 siRNA-1: 5′-CAG CCU UUC GGU CUU CUA UTT-3′, human AnxA8 siRNA-2: GCG UGA 
UGG GAC CCU GAU ATT-3′, human AnxA8 siRNA-3: 5′-GCC CUU AUG UAC CCG CCA UTT-3′54. Cells 
were transfected using Interferin (Polyplus transfection) for 48 h, and each AnxA8 siRNA was added at 150 nM. 
Allstars siRNA (Qiagen) was used as a control. Cells were washed and incubated with full media for another 48 h. 
Phase images were taken, and cells were processed for real-time PCR and immunofluorescence analysis.
Immunofluorescence staining and confocal microscopy. Cells grown on glass coverslips were 
washed with PBS after FR or AnxA8 siRNA treatment, and were then fixed in 4% paraformaldehyde (PFA) for 
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10 min at 4 °C. Cells were incubated in 0.1% Triton X100 (Sigma) for another 10 min, and non-specific binding 
sites were blocked with PBS and 1% BSA for 30 min. Polyclonal rabbit antibodies against human AnxA8 (1:200, 
AP00292PU-N, Acris), calretinin (1:200, Millipore), calbindin (1:200, Swant, Switzerland) and phosphohistone 
H3 (pHH3, 1:200, Cell Signalling) were applied overnight at 4 °C. A secondary Alexa fluor 488 donkey anti-rabbit 
antibody (1:200, Invitrogen) and rhodamine phalloidin (1:200, Invitrogen) were added for 1 h. Nuclei were 
stained with DAPI (1:1000, Sigma). As a negative control, the primary antibody was omitted. Cells were then 
mounted in moviol (Calbiochem), and analysed using confocal microscopy (Leica TCS SP2, LSM Zeiss 710). 
Images were processed in ImageJ (NIH freeware).
Real-time PCR. Total RNA was isolated from ARPE-19 and pRPE cells using the RNeasy Mini Kit (Qiagen). 
RNA concentration was measured with a Nanodrop 1000 Spectrophotometer (Thermo Scientific), and the 
Quantitect RT Kit (Qiagen) was used to reverse transcribe up to 1 µg RNA into cDNA. Real-time amplifica-
tion was performed on a HT7900 Fast Real-Time PCR System (Applied Biosystems). PCR reactions were per-
formed in triplicates with Power Sybr Green master mix (Life Technologies) containing 1 µl cDNA and 0.3 µM 
gene-specific primers (Life Technologies, Table 2). Raw data were transferred into the Dart-PCR spreadsheet 
(version 1.0)55, and gene expression was normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
FR and AnxA8 siRNA treatments were normalised to corresponding controls (DMSO/ctrl siRNA). Dissociation 
curves were generated to assess binding specificity of each primer pair.
AnxA8 overexpression. ARPE-19 cells were transfected at 80–90% confluence using Lipofectamine LTX 
Plus transfection reagent (Life Technologies). According to the manufacturer’s instructions, 2.5 µg AnxA8-GFP27 
or GFP plasmid DNA was used to transfect a dish of 8.55 cm² for 6 h at 37°. Afterwards, cells were washed and FR 
or AnxA8 siRNA treatment was started straight away as described earlier. Phase images were taken after transfec-
tion (day 0), on days 3 and 6 of treatment. GFP-transfected cells were counted and quantified as a percentage of 
the total cell count. Cells were also fixed in 4% PFA after transfection for immunofluorescence analysis to analyse 
neuronal marker and pHH3 expression, or cells were processed for Western blotting to analyse apoptosis.
Western blotting. Equal numbers of cells were lysed in 2% sodium dodecyl sulphate (SDS), 25% glycerol, 
12.5% 0.5 M Tris-HCl pH 7.4, 0.02% dithiothreitol and 0.02% bromophenol blue at 95 °C for 5 min. Samples were 
subjected to SDS-polyacrylamide gel electrophoresis using 10% acrylamide gels, and separated proteins were trans-
ferred to a nitrocellulose membrane at 30 V for 4 h. Non-specific binding sites were blocked using 7% milk powder 
in Tris-buffered saline for 1 h, and the membrane was incubated with caspase-3 (1:2000, Cell signalling) and cleaved 
caspase-3 (1:1000, Cell signalling) antibodies overnight at 4 °C. An HRP-conjugated donkey anti-rabbit secondary 
antibody (Dako) was applied for 1 h. Proteins were visualised using chemiluminescence (GE Healthcare) and exposed 
to Kodak Biomax X-ray films. Grey values of protein bands were normalised to those of heat shock chaperone-70 
(HSC-70, Santa Cruz, 1:5000), and densitometric analysis was undertaken with ImageJ (NIH freeware).
Statistical analysis. Data are presented as mean and standard error. Student’s t-test was performed for nor-
mally distributed data to analyse differences between two groups using Microsoft Excel. Differences with P val-
ues < 0.05 were considered statistically significant. Sample sizes are indicated in the figure legends.
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